A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema
Status: | Completed |
---|---|
Conditions: | Psoriasis, Skin and Soft Tissue Infections, Skin and Soft Tissue Infections, Dermatology |
Therapuetic Areas: | Dermatology / Plastic Surgery |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 2/7/2015 |
Start Date: | July 2013 |
End Date: | August 2014 |
Contact: | Derek V. Chan, MD, PhD |
Email: | derek.chan@osumc.edu |
Phone: | 614.293.1707 |
A Double-Blind Pilot Study To Assess The Feasibility of a Larger Study to Assess The Efficacy of A Novel Gel Wash Cleanser Formulated With Sodium Hypochlorite To Reduce Skin Fauna In Patients With Chronic Hand Dermatitis/Atopic Dermatitis.
The primary objective of this protocol is to acquire pilot data for a larger study to test
the following hypothesis: Treatment of the hands of patients with chronic hand
dermatitis/atopic dermatitis with CLn BodyWash, a novel gel wash cleanser currently marketed
as a cosmetic product containing a dilute concentration of less than 0.01% sodium
hypochlorite and less than 0.005% concentration as it is lathered, will result in a
statistically significant reduction in the number of skin fauna present on the hands of
these patients compared to treatment of such patients with traditional wash used clinically
such as Cetaphil Daily Facial Cleanser.
the following hypothesis: Treatment of the hands of patients with chronic hand
dermatitis/atopic dermatitis with CLn BodyWash, a novel gel wash cleanser currently marketed
as a cosmetic product containing a dilute concentration of less than 0.01% sodium
hypochlorite and less than 0.005% concentration as it is lathered, will result in a
statistically significant reduction in the number of skin fauna present on the hands of
these patients compared to treatment of such patients with traditional wash used clinically
such as Cetaphil Daily Facial Cleanser.
Patients with Hand Eczema will be asked to wash with either a CLn BodyWash or Cetaphil Daily
Facial Cleanser. Patients and study staff will be blinded. Hand swabs will be done prior
to the wash and after 20 minutes. The average time spent in the study for each patient
should be less than 2 hours unless an Adverse Event occurs.
Facial Cleanser. Patients and study staff will be blinded. Hand swabs will be done prior
to the wash and after 20 minutes. The average time spent in the study for each patient
should be less than 2 hours unless an Adverse Event occurs.
Inclusion Criteria:
- Seen by an OSU Dermatology provider at OSU Dermatology East after the date of
approval of this protocol
- Ability to provide informed consent, or parent or legal guardian capable of providing
consent for child or mentally handicapped individuals
- Willingness to participate in a research study.
- Diagnosis of chronic hand dermatitis
Exclusion Criteria:
- Inability to provide informed consent
- Allergy to any of the treatments used
We found this trial at
1
site
Click here to add this to my saved trials